Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01) G01N 33/53 (2006.01) G01N 33/574 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2340721

The present invention provides the sequence of a cell matrix receptor specific for the Cys-Ser-Val-Thr-Cys-Gly (SEQ ID NO:1) region of thrombospondin. Also provided are purification, cloning and expression methods. The receptor protein is useful in numerous diagnostic, prophylactic and therapeutic areas.

La présente invention concerne la séquence d'un récepteur matriciel de cellule, spécifique de la région Cys-Ser-Val-Thr-Cys-Gly (SEQ ID NO:1) de la thrombospondine. L'invention concerne également la purification, le clonage et des procédés d'expression. La protéine réceptrice est utilisée dans de nombreux domaines diagnostiques, prophylactiques et thérapeutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1431022

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.